Leaps by Bayer co-led a $55m series A round for cancer immunotherapy developer Triumvira Immunologics and is getting two board seats.

The medical research services provider received nearly $43.5m in a round that came seven months after an investment from China Life Private Equity.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Intel Capital came in as a new investor for a round that pushed the genome engineering technology provider's overall funding to $260m.

NetScientific and EMV Capital have completed their merger to assemble a portfolio of 15 companies in healthcare, energy and industrial tech.

The TTO reported decreased spinout generation, licensing revenue and funding however marked a notable exit in the sale of Tissue Analytics.

The healthcare data producer raised $19m from investors including Johnson & Johnson for a round already including Amgen, McKesson, Horizon Health Services, Sanofi and UCB Pharma.

Ci:z Investment led a round also backed by CareNet that advanced the total raised by the spinal disease drug developer to more than $70m.

Salesforce Ventures contributed to an $11.5m round that will fund the addition of more features to Acto's mobile drug information platform.

Cancer and fibrosis therapy developer Forbius has agreed to be acquired by Bristol Myers Squibb nine years after it was spun off by YM BioSciences.